ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Lineus Medical Adds New VP of Sales, Larry Hayes

By: PRLog

FAYETTEVILLE, Ark. - June 17, 2024 - PRLog -- Lineus Medical announces that it has added a new executive team member with the hiring of Larry Hayes from Richmond, VA. Larry joins Lineus Medical as Vice President of Sales and leads all sales related efforts for the company.

Larry has over 20 years of experience across the medical device and medical technology field and has worked with 4 different successful early-stage startups. Before becoming Vice President of Sales at Lineus Medical, he was the Vice President Interventional Imaging at GE Healthcare where he led commercial teams in the United States and Canada for GE's Interventional Imaging Systems. He was the Vice President of International Sales, Marketing, and Commercial Strategy at IntroCare where he grew their global sales, and improved their marketing, commercial, regulatory, and medical affairs functions. Larry spent 8 years working abroad growing international sales and relations at EziSurg Medical and Vascular Flow Technologies. Prior to his international experience, Larry held several sales management positions at Banyan Biomarkers and W.L Gore & Associates. He earned a Bachelor of Arts in English at Catawba College.

The CEO of Lineus Medical, Vance Clement, stated, "Larry has a vast experience with startup companies in motivating and leading sales teams.  We have a great product and a good base of customers, and we are excited to work with Larry as we take sales to new heights."

"I'm very excited to join the talented team at Lineus Medical," said Larry Hayes. "The clinical results of the company's flagship product, SafeBreak Vascular, showed significant improvements over the current standard of care, with promising health-economic outcomes that benefit clinicians and their patients1. I'm looking forward to optimizing our commercial strategy and growing sales significantly."

SafeBreak Vascular is the only break-away device for IV lines proven to reduce IV complications.1 When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patent's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money. 1 It's a win-win-win.

About Lineus Medical

Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications.1 Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn.

1.      Data on File

MKG 0269 Rev 00

Contact
Vance Clement
***@lineusmed.com

Photos: (Click photo to enlarge)

Lineus Medical Logo Larry Hayes, VP of Sales for Lineus Medical


Source: Lineus Medical

Read Full Story - Lineus Medical Adds New VP of Sales, Larry Hayes | More news from this source

Press release distribution by PRLog

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.